Clinical trial recruitment marketing: how to fill a trial faster with plain-English content and creators

Most trials miss their enrollment timeline, and the usual reason is not that eligible patients don't exist. It's that the trial is described in language only the study team understands, on a page nobody can find, with a next step nobody wants to take. Recruitment is a marketing problem, and the tools that fix it are the same ones that sell anything hard to explain.

Start with the sentence, cleared by the IRB

"A phase 2 randomized study of X in moderate-to-severe Y" recruits no one. "A study testing whether a new once-a-day pill helps people whose psoriasis hasn't responded to other treatments. Visits every two weeks for six months, at a clinic in Irvine, all study care at no cost" recruits people. Write the plain-language version, get it approved once, and use it everywhere.

A page per trial, built to be found

One page: who it's for in plain terms, what happens during the study, how long, where, what it costs (nothing), what participants get, and a short screener. Structured so search engines and AI assistants can read it when someone types "psoriasis clinical trial near me." Most trials have no such page; the one that does gets the patient.

Patient advocates and creators

A person who has the condition explaining what joining a trial is actually like does more than any ad. Patient advocates, community creators and, where appropriate, prior participants, with IRB-approved scripts. Run on the platforms where that community already talks. Keep the claims to what the protocol says.

The screener funnel with a human at the end

Ad or video, landing page, a five-question pre-screener, and then a person calls within a day. Every step measured: view to click, click to screener, screener to call, call to consent. The step that usually breaks is the call. Automate the reminder and the scheduling, but keep the human.

Sites, not just sponsors

Referring physicians need the same plain-language page and a one-line reason to mention the trial. Site coordinators need a follow-up sequence for people who screened but didn't consent. Both are content and automation problems, and both are cheap next to a missed timeline.